BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 210 filers reported holding BRIDGEBIO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $662,784 | +55.7% | 25,134 | +1.6% | 0.01% | +100.0% |
| Q2 2023 | $425,666 | +31.7% | 24,748 | +27.0% | 0.00% | 0.0% |
| Q1 2023 | $323,161 | +125.3% | 19,491 | +3.5% | 0.00% | +200.0% |
| Q4 2022 | $143,439 | -20.3% | 18,824 | +4.2% | 0.00% | -50.0% |
| Q3 2022 | $180,000 | +10.4% | 18,061 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $163,000 | +0.6% | 18,001 | +13.1% | 0.00% | +100.0% |
| Q1 2022 | $162,000 | -46.5% | 15,915 | -12.3% | 0.00% | -50.0% |
| Q4 2021 | $303,000 | -64.7% | 18,139 | -0.9% | 0.00% | -71.4% |
| Q3 2021 | $858,000 | -22.8% | 18,299 | +0.4% | 0.01% | -22.2% |
| Q2 2021 | $1,111,000 | +18.7% | 18,221 | +19.9% | 0.01% | +12.5% |
| Q1 2021 | $936,000 | – | 15,194 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |